Manic Monday 2 ?31 Mar 2022 18:01
Easy to have given up on this one after what's happened. I'm certainly no scientific expert but looking back over all the positive indications we had on the lead-up to Sprinter readout,is it even possible that this drug and it's patented value are now almost worthless ? Any positive info. clawed from the deep dive,anything standout at all to complement the 36% improvement ontop of SOC,and this deflated SP could shift north quite quickly,as on manic monday.Maybe not to £2+ but £1+ is easily achievable imo on breakout news. The endpoints were missed in the trial because the trial design was faulty,not the drug. There's too much evidence to show that SNG001 almost definately saves lives when people are struggling to breath ( puts out the fire ) and hopefully enough data can be derived from the deep dive to emphasise this probability. It's also easy to forget how important a drug like this,if proven effective,will be as a broad spectrum antiviral and as a stockpiled failsafe against future pandemics.This is AIM,where the SP rarely reflects true value..it's currently in shock mode . I've averaged down to a comfortable level and i'm expecting at least double my money near term.Glad to see that many of the valued posters are still onboard as there's no way the story here is over,not by a long shot.